Prostate Adenocarcinoma
Showing NaN - NaN of 10
Prostate Adenocarcinoma Trial in United States (procedure, drug, dietary supplement)
Not yet recruiting
- Prostate Adenocarcinoma
- Biopsy
- +3 more
-
Los Angeles, California
- +4 more
Sep 7, 2023
Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8, Stage IIA Prostate Cancer AJCC v8 Trial in Chicago (procedure,
Not yet recruiting
- Prostate Adenocarcinoma
- +3 more
- Biopsy of Prostate
- +6 more
-
Chicago, IllinoisNorthwestern University
May 9, 2023
Work Experience in Patients With Stage I-III Prostate Cancer
Recruiting
- Prostate Adenocarcinoma
- +3 more
- Interview
- Questionnaire Administration
-
Phoenix, Arizona
- +324 more
Dec 21, 2022
Prostate Adenocarcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in United States
Recruiting
- Prostate Adenocarcinoma
- +6 more
- Gonadotrophin Releasing Hormone
- +2 more
-
Gilbert, Arizona
- +86 more
Sep 27, 2022
Prostate Adenocarcinoma, Stage I Prostate Adenocarcinoma, Stage II Prostate Adenocarcinoma Trial in Canada, Switzerland, United
Active, not recruiting
- Prostate Adenocarcinoma
- +3 more
- Hypofractionated radiation therapy
- +2 more
-
Birmingham, Alabama
- +240 more
Jun 6, 2022
Hormone-Resistant Prostate Cancer, Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in United States (biological,
Completed
- Hormone-Resistant Prostate Cancer
- +3 more
- Cixutumumab
- +2 more
-
Chicago, Illinois
- +3 more
May 21, 2019
Hormone-Resistant Prostate Cancer, Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in United States (Laboratory
Completed
- Hormone-Resistant Prostate Cancer
- +3 more
- Laboratory Biomarker Analysis
- +2 more
-
Washington, District of Columbia
- +19 more
Aug 13, 2018
Prostate Adenocarcinoma, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in United States (drug, other, procedure)
Completed
- Prostate Adenocarcinoma
- +4 more
- Bicalutamide
- +5 more
-
Los Angeles, California
- +14 more
Sep 18, 2017
Hormone-Resistant Prostate Cancer, Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in United States (drug, other,
Terminated
- Hormone-Resistant Prostate Cancer
- +3 more
- Docetaxel
- +4 more
-
Jacksonville, Florida
- +13 more
Aug 21, 2017
Breast Cancer, NSCLC, Melanoma Trial in United States (131-I-TM-601 (chlorotoxin))
Completed
- Breast Cancer
- +7 more
- 131-I-TM-601 (chlorotoxin)
-
Birmingham, Alabama
- +5 more
Mar 30, 2009